KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada’s Drug Agency (CDA) has recommended WINREVAIR® (sotatercept) for reimbursement in combination with standard… Read More
DehydraTECH™ for GLP-1 being optimized for global pharmaceutical use KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms provides the following… Read More
Getinge appoints Alexandra Holland as the new Executive Vice President of Communications effective November 11, 2024. Alexandra will become a member of the Getinge Executive Team and lead the development,… Read More
Bringing Over Two Decades of Industry Expertise to Expand Access and Strengthen Partnerships Across Canada MISSISSAUGA, ON – Gilead Sciences Canada, Inc. (Gilead Canada) announced that Paul Petrelli joined the organization… Read More
Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell lung cancers VANCOUVER, BC – Zymeworks… Read More
